TWA
SANA icon

TCI Wealth Advisors’s Sana Biotechnology SANA Stock Holding History

TCI Wealth Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-851
Closed -$3.36K – 2618
2022
Q4 		$3.36K Hold
851
– – ﹤0.01% 1798
2022
Q3 		$5K Hold
851
– – ﹤0.01% 1513
2022
Q2 		$5K Buy
+851
New +$5.42K ﹤0.01% 1530
2022
Q1 		– Sell
-294
Closed -$5K – 2425
2021
Q4 		$5K Buy
294
+150
+104% +$2.89K ﹤0.01% 1714
2021
Q3 		$3K Buy
+144
New +$3.02K ﹤0.01% 2000

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

TCI Wealth Advisors's SANA Position: Q1 2023 in Review

TCI Wealth Advisors sold out of Sana Biotechnology (SANA) in Q1 2023, closing a stake of 851 shares — an estimated $3.36K sold.

TCI Wealth Advisors first reported a position in SANA in Q3 2021 and held it in 5 quarters. The position peaked at $5K in Q3 2022. 120 funds tracked by Wall St. Rank hold SANA as of Q1 2023.

  • TCI Wealth Advisors reported no remaining Sana Biotechnology position as of Q1 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 851 Sana Biotechnology shares in Q1 2023, an estimated $3.36K.
  • TCI Wealth Advisors first reported a position in Sana Biotechnology in Q3 2021 and held it in 5 quarters.
  • TCI Wealth Advisors's Sana Biotechnology position peaked at $5K in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2023.

Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.